The thesis sheds light on the most frequent neuroinflammatory disease called Multiple Sclerosis. There's focus on the current and most reliable therapy of the disorder. The thesis also discusses the numerous trials and research of upcoming drugs that have become quite efficient as therapy. There are highlights on the antibody therapy of this immune disorder that have shown promising results for the patients. The therapy of accompanying symptoms have also been revised and discussed.